Increase in Mrp 1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C 57 BL / 6 mice

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart

  2006cited by this paper
• The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity.

  2006cited by this paper
• Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

  2006cited by this paper
• Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System

  2006cited by this paper
• Doxorubicin induces expression of multidrug resistance‐associated protein 1 in human small cell lung cancer cell lines by the c‐jun N‐terminal kinase pathway

  2005cited by this paper
• Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.

  2005cited by this paper
• NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

  2005cited by this paper
• The Role of the Multidrug Resistance Protein-1 in Modulation of Endothelial Cell Oxidative Stress

  2005cited by this paper
• Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: Insight into chemobrain

  2005cited by this paper
• Multidrug Resistance—Associated Protein 1 Functions as an Efflux Pump of Xenobiotics in the Skin

  2005cited by this paper
• Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.

  2005cited by this paper
• Manganese superoxide dismutase and inducible nitric oxide synthase modify early oxidative events in acute Adriamycin-induced mitochondrial toxicity

  2005cited by this paper
• Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats.

  2005influential reference
• Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms.

  2004cited by this paper
• ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE

  2004cited by this paper
• Oxidatively Modified GST and MRP1 in Alzheimer’s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

  2004cited by this paper
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics*

  2003cited by this paper
• Relationship between anti‐oxidant activities and doxorubicin‐induced lipid peroxidation in P388 tumour cells and heart and liver in mice

  2003cited by this paper
• Intracellular metabolism of 4-hydroxynonenal.

  2003cited by this paper
• Mice lacking the multidrug resistance protein 1 have a transiently impaired immune response during tuberculosis

  2002cited by this paper
• Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

  2002cited by this paper
• The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

  2001cited by this paper
• Identification of an Amino Acid Residue in Multidrug Resistance Protein 1 Critical for Conferring Resistance to Anthracyclines*

  2001cited by this paper
• Identification of DNA-protein interactions in the 5' flanking and 5' untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site.

  2001cited by this paper
• Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate.

  2001cited by this paper
• Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4

  2001cited by this paper
• Transport of amphipathic anions by human multidrug resistance protein 3.

  2000cited by this paper
• Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.

  2000cited by this paper
• Multidrug resistance protein mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate.

  2000cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1

  1999cited by this paper
• Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)*

  1999cited by this paper
• Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein*

  1999cited by this paper
• U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adducts.

  1998cited by this paper
• Metabolism of the Lipid Peroxidation Product, 4-Hydroxy-trans-2-nonenal, in Isolated Perfused Rat Heart*

  1998cited by this paper
• Doxorubicin-induced cardiomyopathy.

  1998cited by this paper
• Doxorubicin-induced acute changes in cytotoxic aldehydes, antioxidant status and cardiac function in the rat.

  1997cited by this paper
• Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP.

  1997cited by this paper
• Chapter 7 Protein Oxidation Processes in Aging Brain

  1997cited by this paper
• Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.

  1997cited by this paper
• Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein

  1997cited by this paper
• Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles

  1996cited by this paper
• Tissue distribution of the multidrug resistance protein.

  1996cited by this paper
• The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase.

  1995influential reference
• Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease.

  1994cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

  1991influential reference
• Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

  1990cited by this paper
• ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates. A study using rat heart sarcolemma vesicles.

  1989cited by this paper
• Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart.

  1986cited by this paper
• 4‐Hydroxyalk‐2‐enals are substrates for glutathione transferase

  1985cited by this paper
• Free radical production from normal and adriamycin-treated rat cardiac sarcosomes.

  1985cited by this paper
• Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism.

  1984cited by this paper
• Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity.

  1979cited by this paper
• Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals.

  1978cited by this paper
• Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response.

  1977cited by this paper
• Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity.

  1975cited by this paper

• Physiological and pharmacological characterization of a molluscan neuronal efflux transporter; evidence for age-related transporter impairment

  2020cites this paper
• The 2013 Discovery Award from the Society for Free Radical Biology and Medicine : Selected Discoveries from the Butterfield Laboratory of Oxidative Stress and Its Sequelae in Brain in Cognitive Disorders Exemplified by Alzheimer Disease and Chemotherapy Induced Cognitive Impairment

  2014cites this paper
• 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.

  2011cites this paper